Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Y Melmed

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Urology|July 18, 2001
Life after radical prostatectomy: a longitudinal studyM S Litwin, G Y Melmed, T Nakazon
Alimentary Pharmacology & Therapeutics|January 16, 2004
Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapyR W Dubois, G Y Melmed, J M Henning, et al.
Neurogastroenterology and Motility|December 17, 2016
Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general populationA D Lee, B M Spiegel, R D Hays, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2007
Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivityR W Dubois, D Aguilar, R Fass, et al.
Inflammatory Bowel Diseases|February 17, 2012
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groupsA S Cheifetz, G Y Melmed, B Spiegel, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Urology|July 18, 2001
Life after radical prostatectomy: a longitudinal studyM S Litwin, G Y Melmed, T Nakazon
Alimentary Pharmacology & Therapeutics|January 16, 2004
Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapyR W Dubois, G Y Melmed, J M Henning, et al.
Neurogastroenterology and Motility|December 17, 2016
Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general populationA D Lee, B M Spiegel, R D Hays, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2007
Consequences of frequent nocturnal gastro-oesophageal reflux disease among employed adults: symptom severity, quality of life and work productivityR W Dubois, D Aguilar, R Fass, et al.
Inflammatory Bowel Diseases|February 17, 2012
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groupsA S Cheifetz, G Y Melmed, B Spiegel, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Pageof 1